当前位置:首页 - 行情中心 - 中国医药(600056) - 财务分析

中国医药

(600056)

  

流通市值:167.18亿  总市值:167.24亿
流通股本:14.95亿   总股本:14.96亿

中国医药(600056)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润7.84亿元,每股收益0.40元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益1368831.91万元,未分配利润703662.69万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产3818620.50万元,负债2449788.58万元。

利润表
报告期2023-09-302023-06-302023-03-312022-12-31
营业总收入29,796,767,468.521,624,971,226.5412,530,663,199.1837,592,649,532.91
营业总成本28,684,951,933.5620,720,802,502.0312,093,668,632.7936,137,940,473.13
营业利润1,105,488,870.09873,142,857.99406,844,907.961,199,697,983.22
利润总额1,109,150,508.67874,300,636.47406,610,349.261,196,127,041.17
净利润783,662,782.78676,753,330.14320,582,342.33887,968,198.44
其他综合收益706,621.641,619,270.62225,522.188,059,188.2
综合收益总额784,369,404.42678,372,600.76320,807,864.51896,027,386.64
资产负债表
报告期2023-09-302023-06-302023-03-312022-12-31
流动资产合计29,069,805,205.2430,359,190,079.0129,749,985,189.1926,934,508,275.72
非流动资产合计9,116,399,770.669,098,138,315.768,860,059,934.198,964,104,296.36
资产总计38,186,204,975.939,457,328,394.7738,610,045,123.3835,898,612,572.08
流动负债合计19,038,386,996.0819,834,099,238.7519,244,639,65418,012,744,990.15
非流动负债合计5,459,498,840.925,983,836,541.425,871,407,114.684,712,780,511.27
负债合计24,497,885,83725,817,935,780.1725,116,046,768.6822,725,525,501.42
归属于母公司股东权益合计11,189,878,36711,140,228,113.4611,084,871,359.5810,815,778,221.23
股东权益合计13,688,319,138.913,639,392,614.613,493,998,354.713,173,087,070.66
负债和股东权益合计38,186,204,975.939,457,328,394.7738,610,045,123.3835,898,612,572.08
现金流量表
报告期2023-09-302023-06-302023-03-312022-12-31
经营活动现金流入小计31,194,325,174.5521,437,689,929.5711,447,801,438.6740,728,172,815.34
经营活动现金流出小计31,528,464,465.6422,043,905,036.5412,939,628,069.5739,082,300,324.15
经营活动产生的现金流量净额-334,139,291.09-606,215,106.97-1,491,826,630.91,645,872,491.19
投资活动现金流入小计34,854,631.9334,803,799.034,727,104.32291,786,834.69
投资活动现金流出小计262,523,592.54147,933,96469,189,582.12269,647,477.16
投资活动产生的现金流量净额-227,668,960.61-113,130,164.97-64,462,477.822,139,357.53
筹资活动现金流入小计3,599,631,482.123,314,631,481.923,007,281,481.924,050,216,420.89
筹资活动现金流出小计4,102,397,721.753,202,413,751.332,823,851,137.984,052,240,161.96
筹资活动产生的现金流量净额-502,766,239.63112,217,730.59183,430,343.94-2,023,741.07
汇率变动对现金及现金等价物的影响3,132,252.11-3,899,436.5-341,659.6610,742,234.99
现金及现金等价物净增加额-1,061,442,239.22-611,026,977.85-1,373,200,424.421,676,730,342.64
期末现金及现金等价物余额2,449,601,992.272,900,017,253.642,137,843,807.073,511,044,231.49
TOP↑